Evaluating URMC's Massive Transfusion Protocol

CompletedOBSERVATIONAL
Enrollment

2

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

December 16, 2014

Study Completion Date

December 16, 2014

Conditions
Blood Coagulation DisordersTraumaAcute Coagulopathy
Interventions
OTHER

Blood collection

After transfusion of each shipment of blood products outlined in the current Massive Transfusion Protocol one 2.7mL citrated blood sample will be collected from the subject through the 5th shipment of blood products. A final sample will be collected 24 hours following the discontinuation of the massive transfusion protocol.

Trial Locations (1)

14642

Strong Hospital at University of Rochester Medical Center, Rochester

All Listed Sponsors
lead

University of Rochester

OTHER

NCT02083549 - Evaluating URMC's Massive Transfusion Protocol | Biotech Hunter | Biotech Hunter